The call highlighted significant strategic achievements, including strengthening the market access team and positive progress towards Medicare coverage, which are expected to drive future growth. However, the company faced flat revenue growth and ongoing reimbursement challenges, impacting short-term financial performance.

Company Guidance

During the Lucid Diagnostics Inc. Third Quarter 2025 Business Update Conference Call, the company provided key metrics and insights regarding its performance and future outlook. The company reported a test volume of 2,841 tests and revenue of approximately $1.2 million for the third quarter, maintaining its target range of 2,500 to 3,000 tests per quarter. The balance sheet was strengthened with a $27 million public offering, resulting in $47 million in pro forma cash at quarter-end. The quarterly burn rate was $10.3 million, consistent with previous quarters. Lucid is focusing on expanding Medicare patient targeting, with up to 50% of its 30 million target population being Medicare-eligible. The company is also in the final stages of securing Medicare coverage for its EsoGuard test, following a positive Medicare Contract Advisory Committee (CAC) meeting. Additionally, Lucid is actively engaging with commercial payers, anticipating increased coverage beyond Medicare.

Strengthened Market Access Team

Lucid Diagnostics has recruited a world-class market access team led by Danielle Shelfo, bringing strong relationships in the commercial payer space to secure coverage and reimbursement across major insurers.

Positive Medicare Coverage Progress

The Medicare Contract Advisory Committee meeting was extremely positive, with unanimous endorsement for EsoGuard Medicare coverage, potentially leading to a significant increase in future revenue.

Successful Financing and Strong Balance Sheet

Lucid Diagnostics completed an underwritten public offering, netting approximately $27 million, bolstering the balance sheet with $47 million in pro forma cash, extending the runway through 2026.

Firefighter Esophageal Cancer Prevention Summit

Lucid Diagnostics is hosting its first firefighter esophageal cancer prevention summit, fostering relationships with fire departments to bolster the pipeline of contracted testing events.

Lucid Diagnostics (LUCD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

LUCD Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Mar 30, 2026	2025 (Q4)	-0.10 / -	-0.19	―	―	―
Nov 12, 2025	2025 (Q3)	-0.10 / -0.10	-0.2	50.00% (+0.10)
Aug 13, 2025	2025 (Q2)	-0.11 / -0.10	-0.2	50.00% (+0.10)	―
May 14, 2025	2025 (Q1)	-0.15 / -0.16	-0.99	83.84% (+0.83)	―
Mar 24, 2025	2024 (Q4)	-0.18 / -0.19	-1.33	85.71% (+1.14)	―
Nov 13, 2024	2024 (Q3)	-0.21 / -0.20	-0.22	9.09% (+0.02)	―
Aug 12, 2024	2024 (Q2)	-0.20 / -0.20	-0.23	13.04% (+0.03)	―
May 13, 2024	2024 (Q1)	-0.24 / -0.99	-0.24	-312.50% (-0.75)	―
Mar 25, 2024	2023 (Q4)	-0.23 / -1.33	-0.33	-303.03% (-1.00)	―
Nov 13, 2023	2023 (Q3)	-0.24 / -0.22	-0.28	21.43% (+0.06)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

LUCD Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 12, 2025	$1.04	$1.11	+6.73%
Aug 13, 2025	$1.00	$0.98	-2.00%
May 14, 2025	$1.19	$1.28	+7.56%
Mar 24, 2025	$1.52	$1.50	-1.32%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Lucid Diagnostics Inc. (LUCD) report earnings?

Lucid Diagnostics Inc. (LUCD) is schdueled to report earning on Mar 30, 2026, After Close (Confirmed).

What is Lucid Diagnostics Inc. (LUCD) earnings time?

Lucid Diagnostics Inc. (LUCD) earnings time is at Mar 30, 2026, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is LUCD EPS forecast?

LUCD EPS forecast for the fiscal quarter 2025 (Q4) is -0.1.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing